ArticleBMC cancer2015

Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors.

Oreekha Amin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.